J9059 HCPCS Level II code: Injection, bendamustine hydrochloride (baxter), 1 mg
CMS terminated J9059: its last date of service was Dec 31, 2024. It stays here for looking up older claims; newer services need a current code.
Official description
J9059Injection, bendamustine hydrochloride (baxter), 1 mg
Short description: Inj bendamustine, baxter 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9059 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jul 1, 2023
- Terminated after
- Dec 31, 2024
Where J9059 sits
- 1J codesDrugs administered other than orally
- 2Terminated J9059Injection, bendamustine hydrochloride (baxter), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J9059 still valid?
No. CMS terminated J9059; its last date of service was Dec 31, 2024. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J9059?
CMS lists J9059’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9059
All J codesJ9053Injection, belantamab mafodotin-blmf, 0.1 mgJ9054Injection, bortezomib (boruzu), 0.1 mgJ9055Injection, cetuximab, 10 mgJ9056Injection, bendamustine hydrochloride (vivimusta), 1 mgJ9057Injection, copanlisib, 1 mgJ9058Injection, bendamustine hydrochloride (apotex), 1 mgJ9060Injection, cisplatin, powder or solution, 10 mgJ9061Injection, amivantamab-vmjw, 2 mgJ9062Injection, amivantamab 5 mg and hyaluronidase-lpujJ9063Injection, mirvetuximab soravtansine-gynx, 1 mgJ9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mgJ9065Injection, cladribine, per 1 mg